FDA Approves First Gene Therapy for Bladder Cancer
Patients with BCG-unresponsive bladder cancer had limited treatment options other than bladder removal surgery. The approval of Adstiladrin is therefore a great advance in the current treatment landscape and provides a novel treatment option.
